Funding for this research was provided by:
Ecuphar veterinaria slu-Generalitat de Catalunya PhD industrial
Received: 21 January 2022
Accepted: 21 March 2022
First Online: 10 May 2022
: No ethics approval was needed for this study as only retrospective information was collected. Signed informed consent about information used was obtained from veterinarians.
: Not applicable.
: JH and CM have financial competing interests as they receive a salary from Ecuphar veterinaria SLU which markets both Leisguard<sup>®</sup> and Leiscan<sup>®</sup>.